TriSalus Life Sciences Warrant
TLSIW
19 hedge funds and large institutions have $3.71M invested in TriSalus Life Sciences Warrant in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 4 closing their positions.
11% more capital invested
Capital invested by funds: $3.33M → $3.71M (+$376K)
1.76% less ownership
Funds ownership: 9.84% → 8.07% (-1.8%)
10% less funds holding
Funds holding: 21 → 19 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bluefin Capital Management
New York
|
+$157K |
| 2 |
CCC
Cable Car Capital
San Francisco,
California
|
+$103K |
| 3 |
FVWA
Foster Victor Wealth Advisors
Greenville,
South Carolina
|
+$251 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$170K |
| 2 |
EAM
Exos Asset Management
New York
|
-$168K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$117K |
| 4 |
KL
KIM LLC
Wichita,
Kansas
|
-$81.4K |
| 5 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$58.9K |
TLSIW Hedge Fund Activity: Q2 2024 in Review
19 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q2 2024, worth a combined $3.71M — up 11% from $3.33M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of TLSIW and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 1 added.
The largest buyer was Bluefin Capital Management, opening a new position worth an estimated $157K. The largest seller was Magnetar Financial, cutting an estimated $170K.
- 19 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q2 2024, down from 21 in Q1 2024.
- Funds reported $3.71M of TriSalus Life Sciences Warrant stock for Q2 2024, up 11% quarter-over-quarter.
- 2 funds opened new TriSalus Life Sciences Warrant positions in Q2 2024 and 4 closed out, a net change of -2 holders.
- The largest TriSalus Life Sciences Warrant buyer in Q2 2024 was Bluefin Capital Management, an estimated $157K added.
- The largest TriSalus Life Sciences Warrant seller in Q2 2024 was Magnetar Financial, an estimated $170K sold.
Based on aggregated 13F filings for Q2 2024.